We are live on ! Find out more
TCA

Transcend Capital Advisors Portfolio holdings

AUM $1.25B
1-Year Est. Return 17.69%
This Fund
S&P 500
This Quarter Est. Return
-13.41%
1 Year Est. Return
+17.69%
3 Year Est. Return
+61.21%
5 Year Est. Return
+70.44%
10 Year Est. Return
AUM
$961M
AUM Growth
-$157M
Cap. Flow
+$6.86M
Cap. Flow %
0.71%
Top 10 Hldgs %
26.09%
Holding
555
New
40
Increased
201
Reduced
190
Closed
58

Sector Composition

Rank Sector Weight
1 Technology 17.59%
2 Financials 16.79%
3 Healthcare 9.84%
4 Consumer Discretionary 4.6%
5 Communication Services 4.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UROY
476
Uranium Royalty Corp
UROY
$540M
$124K 0.01%
54,700
OMEX icon
477
Odyssey Marine Exploration
OMEX
$37.9M
$110K 0.01%
32,300
KD icon
478
Kyndryl
KD
$2.98B
$108K 0.01%
10,999
-151
-1% -$1.76K
VTRS icon
479
Viatris
VTRS
$20.7B
$106K 0.01%
10,167
-59
-0.6% -$647
DNA icon
480
Ginkgo Bioworks
DNA
$528M
$104K 0.01%
1,089
TEVA icon
481
Teva Pharmaceuticals
TEVA
$41.2B
$97K 0.01%
12,850
SWN
482
DELISTED
Southwestern Energy Company
SWN
$92K 0.01%
14,681
RKT icon
483
Rocket Companies
RKT
$37.5B
$85K 0.01%
+11,500
New +$99.3K
SOFI icon
484
SoFi Technologies
SOFI
$21.1B
$81K 0.01%
15,325
-1,350
-8% -$9.12K
OPK icon
485
Opko Health
OPK
$993M
$78K 0.01%
30,850
-2,000
-6% -$5.83K
CFRX
486
DELISTED
ContraFect Corporation
CFRX
$68K 0.01%
278
OPAD icon
487
Offerpad Solutions
OPAD
$19.6M
$65K 0.01%
+200
New +$134K
FLNT
488
Fluent
FLNT
$104M
$60K 0.01%
8,375
HLGN
489
DELISTED
Heliogen, Inc.
HLGN
$45K ﹤0.01%
608
APPH
490
DELISTED
AppHarvest, Inc. Common Stock
APPH
$44K ﹤0.01%
12,500
SNCR
491
DELISTED
Synchronoss Technologies
SNCR
$35K ﹤0.01%
3,392
ELVT
492
DELISTED
Elevate Credit, Inc.
ELVT
$24K ﹤0.01%
10,000
GSV
493
DELISTED
Gold Standard Ventures Corp.
GSV
$22K ﹤0.01%
70,000
APTO
494
DELISTED
Aptose Biosciences, Inc.
APTO
$18K ﹤0.01%
53
CELG.RT
495
Bristol-Myers Squibb Rights
CELG.RT
$187M
$16K ﹤0.01%
117,775
SNDL icon
496
Sundial Growers
SNDL
$325M
$13K ﹤0.01%
4,000
OTLK icon
497
Outlook Therapeutics
OTLK
$194M
$10K ﹤0.01%
500
ACM icon
498
Aecom
ACM
$9.22B
-7,230
Closed -$555K
ARKG icon
499
ARK Genomic Revolution ETF
ARKG
$1.6B
-4,842
Closed -$222K
ASML icon
500
ASML
ASML
$634B
-373
Closed -$249K

Similar funds

Transcend Capital Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Transcend Capital Advisors held 555 positions worth $961M, down 14% from $1.12B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Transcend Capital Advisors's Q2 2022 filing shows 40 new, 201 increased, 190 reduced and 58 closed positions. Its largest new stake was State Street SPDR S&P Global Natural Resources ETF: 24,944 shares worth $1.3M. The largest sale was State Street SPDR S&P Regional Banking ETF, an estimated $2.24M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

  • Transcend Capital Advisors's largest Q2 2022 buy was State Street SPDR S&P Global Natural Resources ETF: 24,944 shares worth $1.3M.
  • Transcend Capital Advisors added most to iShares MBS ETF in Q2 2022, an estimated $3.43M increase.
  • Transcend Capital Advisors's biggest Q2 2022 reduction was State Street SPDR Portfolio Short Term Corporate Bond ETF, cutting an estimated $1.71M.
  • Transcend Capital Advisors fully exited State Street SPDR S&P Regional Banking ETF in Q2 2022, selling an estimated $2.24M.
  • Transcend Capital Advisors's ten largest holdings make up 26% of its $961M portfolio in Q2 2022.
  • Transcend Capital Advisors opened 40 new positions and closed 58 in Q2 2022.
  • Transcend Capital Advisors's portfolio value fell 14% quarter-over-quarter to $961M.

Based on Transcend Capital Advisors's 13F filing for Q2 2022, filed 12 Jul 2022.